Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, California
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- N/A
- Filings on record
- 273 filings
- On EDGAR
- CIK 1888886
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 18
News 8 of 37
Prospectuses and Registrations 8 of 14
- 424B5 Prospectus supplement for an offering May 7, 2026
- S-8 Registration statement for an employee plan Feb 26, 2026
- 424B5 Prospectus supplement for an offering Dec 10, 2025
- 424B5 Prospectus supplement for an offering Dec 8, 2025
- S-3ASR Automatic shelf registration Aug 6, 2025
- S-8 Registration statement for an employee plan Feb 27, 2025
- 424B4 Final prospectus for an offering Jun 6, 2024
- S-1 Registration statement for an offering Jun 3, 2024
Proxies 3
Ownership 8 of 159
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 5, 2026
- 4 Insider reported a trade Sep 22, 2026
- 144 Notice of a proposed sale of restricted stock Sep 21, 2026
- 4 Insider reported a trade Sep 2, 2026
- 4 Insider reported a trade Aug 19, 2026
- 4 Insider reported a trade Aug 7, 2026
- 3 Insider reported their initial holding Aug 7, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 6, 2026
Other 8 of 42
- ARS Annual report sent to shareholders Apr 23, 2026
- ARS Annual report sent to shareholders Apr 24, 2025
- EFFECT Notice that a registration became effective Jun 5, 2024
- S-1MEF Jun 5, 2024
- UPLOAD Comment letter from SEC staff Jun 4, 2024
- CORRESP Reply to SEC staff Jun 3, 2024
- CORRESP Reply to SEC staff Jun 3, 2024
- CORRESP Reply to SEC staff May 31, 2024
Everything here comes from Structure Therapeutics Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.